OTC Markets EXMKT - Delayed Quote USD

Rapid Nutrition PLC (RPNRF)

Compare
0.0100 0.0000 (0.00%)
At close: January 7 at 3:00:00 PM EST
Loading Chart for RPNRF
DELL
  • Previous Close 0.0000
  • Open 0.0100
  • Bid --
  • Ask --
  • Day's Range 0.0100 - 0.0100
  • 52 Week Range 0.0100 - 0.0100
  • Volume 52,701
  • Avg. Volume 0
  • Market Cap (intraday) 762,226
  • Beta (5Y Monthly) -1.42
  • PE Ratio (TTM) --
  • EPS (TTM) -2.7600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rapid Nutrition PLC, a natural healthcare company, develops and distributes a rage of science-based health and wellness products worldwide. The company offers organic and natural scientific-based health foods, including various high-protein shakes, organic superfoods, vegan powders, natural metabolism boosters, and immune boosting formulas under the SystemLS brand; and plant-based products. It also provides a blend of herbs for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travellers under the Azuren brand name. Rapid Nutrition PLC was founded in 2001 and is based in Mildenhall, the United Kingdom.

www.rnplc.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RPNRF

View More

Performance Overview: RPNRF

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

RPNRF
0.00%
CAC 40
2.40%

1-Year Return

RPNRF
0.00%
CAC 40
0.93%

3-Year Return

RPNRF
80.00%
CAC 40
3.31%

5-Year Return

RPNRF
90.74%
CAC 40
24.54%

Compare To: RPNRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RPNRF

View More

Valuation Measures

Annual
As of 1/7/2025
  • Market Cap

    3.34M

  • Enterprise Value

    2.70M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -240.99%

  • Return on Assets (ttm)

    -137.65%

  • Return on Equity (ttm)

    -280.87%

  • Revenue (ttm)

    1.28M

  • Net Income Avi to Common (ttm)

    -3.09M

  • Diluted EPS (ttm)

    -2.7600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.03M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.09M

Research Analysis: RPNRF

View More

Company Insights: RPNRF

Research Reports: RPNRF

View More

People Also Watch